Tesla (TSLA, Financials) founder Elon Musk and a group of investors have made an unsolicited $97.4 billion bid to acquire the ...
3h
Investor's Business Daily on MSNTravere Therapeutics Skyrockets After Reaching FDA Deal For Kidney Disease DrugTravere Therapeutics reached an agreement Tuesday on what data the FDA would require to approve its drug for a kidney disease.
Raymond James analyst Brian Vaccaro, who reiterated a market-perform rating on McDonald's, was less bullish. He said U.S. comparable visibility remains cloudy in the near term given continued softness ...
Wedbush said Palantir Technologies (PLTR) and Salesforce (CRM) remain the two best software plays on the AI Revolution for 2025.
Super Micro Computer (SMCI) stock gained nearly 18% yesterday, ahead of its most anticipated Q2 FY25 results. The question ...
Investment analysts at Wedbush cut their FY2025 earnings per share estimates for Advanced Micro Devices in a research report issued on Wednesday, February 5th. Wedbush analyst M. Bryson now expects ...
Investment analysts at Wedbush increased their FY2025 earnings per share (EPS) estimates for Electronic Arts in a research report issued to clients and investors on Wednesday, February 5th. Wedbush ...
Super Micro Computer Inc. shares notched their longest winning streak in about six months ahead of a scheduled "business update" Tuesday. But one analyst just reminded investors that there are still ...
Rivian announced on Monday that it is opening up orders for its Rivian Commercial van beyond its initial launch partners, ...
The server maker’s stock was up more than 13% intraday Monday and has gained over 50% since the update was announced on Feb. 3. Supermicro faces a Feb. 25 deadline to submit its delayed annual report ...
According to 4.5-star Wedbush Securities analyst Dan Ives, the broader software industry is now set to benefit from the exploding use cases of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results